PRKCD and periodontitis: In conclusion, the present study showed that CV directly promoted osteoclast differentiation via PKC-δ/ERK signaling and that CV was associated with the exacerbation of periodontal bone resorption induced in a mouse model of periodontitis, indicating that CV may serve as a candidate therapeutic molecule for future drug developments in the treatment and/or diagnosis of periodontitis.